Amylin Will Add Pancreatitis Cautions To Byetta Label
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues Medwatch alert warning health care professionals of 30 cases of acute pancreatitis in patients taking the type 2 diabetes drug
You may also be interested in...
Phase II Diabetes Data Heighten Incyte’s Partnership Appeal
Novel compound that acts on cortisol gives DPP-4 inhibitors a run for their money.
Phase II Diabetes Data Heighten Incyte’s Partnership Appeal
Novel compound that acts on cortisol gives DPP-4 inhibitors a run for their money.
Byetta Safety Concerns Could Set Roadblocks Ahead For New GLP-1s
Amylin/Lilly’s Byetta LAR and Novo Nordisk’s liraglutide could face tougher regulatory scrutiny after cases of pancreatitis are linked to exenatide.